- Home
- RCUS vs EXK Comparison
RCUS vs EXK Comparison
Compare RCUS & EXK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RCUS | EXK |
|---|---|---|
| Founded | 2015 | 1981 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 2.7B |
| IPO Year | 2018 | 2004 |
Fundamental Metrics
Financial Performance| Metric | RCUS | EXK |
|---|---|---|
| Price | $25.23 | $8.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 8 |
| Target Price | ★ $39.91 | $15.50 |
| AVG Volume (30 Days) | 1.5M | ★ 7.2M |
| Earning Date | 10-27-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $247,000,000.00 | N/A |
| Revenue This Year | N/A | $99.57 |
| Revenue Next Year | N/A | $20.06 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $13.21 | $6.60 |
| 52 Week High | $31.74 | $15.15 |
Technical Indicators
Market Signals| Indicator | RCUS | EXK |
|---|---|---|
| Relative Strength Index (RSI) | 45.70 | 36.02 |
| Support Level | $25.94 | $8.52 |
| Resistance Level | $26.43 | $8.83 |
| Average True Range (ATR) | 1.07 | 0.43 |
| MACD | 0.10 | -0.21 |
| Stochastic Oscillator | 58.61 | 1.21 |
Price Performance
Historical ComparisonAbout RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.
About EXK Endeavour Silver Corporation (Canada)
Endeavour Silver Corp is a Canadian mineral company engaged in the evaluation, acquisition, exploration, development, and exploitation of precious metal properties in Mexico and Chile. The Company has three operating mining segments namely; Guanacevi and Terronera in Mexico, and Minera Kolpa in Peru. The company has one development project in Mexico, Terronera, as well as Exploration and Corporate segments. The Exploration segment consists of projects in the exploration and evaluation phases in Mexico, Chile, and the USA.